Azapropazone and warfarin
Beeley, L.
Bmj 302(6788): 1341
1991
ISSN/ISBN: 0959-8138 PMID: 2059705 Document Number: 374148
Document emailed within 1 workday
Related Documents
Faust-Tinnefeldt, G.F.; Geissler, H.E. 1978: Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone Arzneimittel-Forschung 28(2): 337-341Scott, E.A.; Sandler, G.A.; Byars, T.D. 1978: Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony American Journal of Veterinary Research 39(12): 1888-1891
Koefoed, B.G.; Feddersen, C.; Gulløv, A.L.; Petersen, P. 1997: Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation Thrombosis and Haemostasis 77(5): 845-848
Helleberg, L. 1981: Azapropazone (Prolixan) Ugeskrift for Laeger 143(20): 1286-1287
Gikalov, I.; Kaufmann, R.; Schuster, O. 1982: Human pharmacokinetics of different I.v. doses of azapropazone (HPLC-determination) Arzneimittel-Forschung 32(4): 423-426
Fenner, H.; Mixich, G. 1973: NMR studies on the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation Arzneimittel-Forschung 23(5): 667-669
Gulløv, A.L.; Koefoed, B.G.; Petersen, P.; Pedersen, T.S.; Andersen, E.D.; Godtfredsen, J.; Boysen, G. 1998: Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Archives of Internal Medicine 158(14): 1513-1521
Templeton, J.S. 1982: Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report British Journal of Clinical Practice 36(10): 353-358
Geissler, H.E.; Mutschler, E.; Faust-Tinnefeldt, G. 1977: On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography Arzneimittel-Forschung 27(9): 1713-1715
Faust-Tinnefeldt, G.; Geissler, H.E.; Mutschler, E. 1977: Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents Arzneimittel-Forschung 27(11): 2153-2157
Schrüffer, H.; Stein, W. 1979: A double-blind comparative study of the analgesic effect of Azapropazone, alone or in combination with dextropropoxyphen Schweizerische Rundschau für Medizin Praxis 68(29): 950-957
Farrier, D.S. 1974: Spectroscopic methods for the determination of azapropazone in serum developed and evaluated using radio-isotopic techniques Arzneimittel-Forschung 24(5): 747-751
Stiefelhagen, P. 2011: Is the era from the end of warfarin? Medizinische Monatsschrift für Pharmazeuten 34(6): 209-211
Mott, F.E.; Murphy, S.; Hunt, V. 1989: Ciprofloxacin and warfarin Annals of Internal Medicine 111(6): 542-543
2013: Choose warfarin Prescrire International 22(139): 158
Stuart, J.J. 1978: The use of heparin and warfarin as anticoagulants North Carolina Medical Journal 39(8): 482-485
Ahmad, S. 1991: Omeprazole-warfarin interaction Southern Medical Journal 84(5): 674-675
Jolobe, O.M. 1993: Aspirin, warfarin and stroke British Journal of Hospital Medicine 50(5): 281
Robinson, A.; Liau, F.O.; Routledge, P.A.; Backhouse, G.; Spragg, B.P.; Bentley, D.P. 1990: Lipids and warfarin requirements Thrombosis and Haemostasis 63(1): 148-149
Liebeschuetz, S.; Baddeley, H.; Thomas, D.J. 1994: Haematomyelia following warfarin therapy British Journal of Clinical Practice 48(2): 105-106